跳至主要内容
临床试验/EUCTR2007-001987-55-ES
EUCTR2007-001987-55-ES进行中(未招募)不适用

A randomised trial assessing whether preoperative chemotherapy improves outcome in high-risk operable colon cancer - FOxTROT

niversity Of Birmingham0 个研究点目标入组 1,050 人开始时间: 2015年4月14日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,050

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Histologically proven adenocarcinoma of the colon or high grade dysplasia on histology plus unequivocal radiological evidence of invasive cancer
  • - A candidate for adjuvant oxaliplatin/ fluoropyrimidine chemotherapy based on:
  • Either radiological high risk (rT4 or rT3 tumour with extramural extension ? 5mm)
  • Or radiological intermediate risk (rT3 tumour with <5mm extramural extension) and younger age/good general health
  • - Patients presenting with acute colonic obstruction may enter the trial only after obstruction is relieved by a successful defunctioning stoma, and when recovered to a fitness level consistent with the other eligibility criteria
  • - Adequate full blood count: WBC >3.0 x109/l; Plts >100 x109/l. Anaemia (Hb < 10.0 g/dl) is not an exclusion, but should be corrected by transfusion prior to surgery and chemotherapy
  • - Adequate renal biochemistry: GFR >50 ml/min calculated by the Wright or Cockroft formula or EDTA clearance >70 ml/min
  • - Adequate hepatobiliary function: bilirubin < 25 ?mol/l
  • - Aged 18 or over
  • - WHO performance status of 0, 1 or 2
  • - If female and of childbearing potential, must:
  • Have a negative pregnancy test ?72hours prior to initiating study treatment
  • Agree to avoid pregnancy during and for 6 months after study treatment
  • - If male with a partner of childbearing potential, must:
  • Agree to use adequate, medically approved, contraceptive precautions during and for 90 days after the last dose of study treatment
  • - Patient able and willing to provide written informed consent for the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1020
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • - Any patient for whom radiotherapy is advised by the MDT
  • - Strong evidence of distant metastases or peritoneal nodules (M1)
  • - Peritonitis (secondary to perforated tumour)
  • - Colonic obstruction that has not been defunctioned
  • - Serious medical comorbidity, eg uncontrolled inflammatory bowel disease, uncontrolled angina or recent (<6 months) MI
  • - Another serious medical condition judged to compromise ability to tolerate neoadjuvant therapy and/or surgery
  • - Any other malignant disease within the preceding 5 years with the exception of non-melanomatous skin cancer, carcinoma in situ and early stage disease with a recurrence risk <5%

研究者

相似试验